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Abstract
Purpose Supporting someone through chemotherapy can be
emotionally and physically demanding. However, research
has yet to establish the type of support carers require or the
best way to provide this. This study tested the feasibility and
acceptability of a complex intervention for carers that was co-
designed by staff and carers of patients starting chemotherapy.
Methods Forty-seven carers were recruited, randomised be-
tween the intervention (n=24) and control (n=23) groups. A
questionnaire was completed pre- and post-intervention mea-
suring knowledge of chemotherapy and its side effects, expe-
rience of care, satisfaction with outpatient services, coping
and emotional wellbeing. The intervention process was eval-
uated by carers and healthcare professionals (HCPs) in focus
groups.
Results Recruitment to the study was unproblematic and at-
trition from it was low, suggesting the intervention and study
processes were acceptable to patients and carers. Carers in
receipt of the ‘Take Care’ intervention reported statistically
significantly better understanding of symptoms and side ef-
fects and their information needs being more frequently met
than carers in the control. Confidence in coping improved
between baseline and follow-up for the intervention group
and declined for the control although differences were insuf-
ficient to achieve statistical significance. There was no signif-
icant difference between the two groups’ emotional wellbeing.
HCP and carer focus groups confirmed the feasibility and
acceptability of the intervention.
Conclusions The ‘Take Care’ intervention proved acceptable
to carers and HCPs and demonstrates considerable promise
and utility in practice. Study findings support the conduct of
a fully powered RCT to determine the intervention’s effective-
ness and cost-effectiveness.
Keywords Carers . Chemotherapy . Support . Intervention
Background
Chemotherapy is the mainstay for treating some of the most
common cancers including breast and colorectal cancer. Many
regimens are administered in ambulatory settings. Conse-
quently, patients benefit from remaining at home during treat-
ment but have limited contact with hospital healthcare profes-
sionals (HCPs), usually only seeing them when treatment is
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administered [1]. Thus, patients and carers (their family/
friends) assume responsibility for monitoring and managing
treatment side effects and contacting HCPs if patients become
unwell [2, 3].
It is now well established that carers perform many vital
roles to ensure patients are supported and safe whilst at home
[4–6]. These roles require assistance from HCPs. Indeed, clin-
ical practice guidelines for psychosocial and supportive cancer
care offered to adults with cancer produced by countries in-
cluding the UK [7], USA [8], Canada [9] and Australia [10] as
well as multinational organisations [11] stress the need for
cancer care services to enhance support provided to carers.
Research exploring carers’ experiences of supporting pa-
tients through chemotherapy depicts it as an intensely anxiety-
provoking time characterised by concerns over managing pa-
tient side effects [2, 5]. Substantial numbers of carers are not
provided with the information needed to help them care for
patients at home; there appears considerable variation in prac-
tice with regard to the support they are provided [12]. A review
of international literature relating to the information needs of
family members of cancer patients showed that many experi-
enced negative interactions with HCPs including being ignored,
experiencing lack of empathy and compassion and receiving
ambiguous and sometimes conflicting information [13]. Argu-
ably, inadequate or conflicting information may result in carers
being slow in recognising important changes in patients’ health.
It is suggested that carers of cancer patients may themselves
risk mental and physical ill health if their needs for information
and support are not addressed and they perceive themselves ill
equipped to care [14–16]. Their needs tend to be overlooked;
carers’ contribution is often unrecognised and underestimated
by HCPs [17]. This may account for the dissatisfaction report-
ed by carers supporting patients through chemotherapy [18].
They report ‘feeling abandoned’ [16], with their own needs for
information and support often unmet [5, 12, 16].
Few intervention studies for improving the experiences and
outcomes of carers of patients with cancer undergoing active
treatment have been developed or tested [19–21]. None have
been developed to support carers of people having chemother-
apy. Most research addresses needs of carers of patients with
advanced disease [22–27]. The most successful interventions
are typically complex and frequently incorporate tailored
nurse-led support to address carers’ emotional, practical, so-
cial and information needs [20, 21, 28]. This research project
tested the feasibility and acceptability of a complex interven-
tion co-designed—together with staff—by carers of patients
starting chemotherapy. It is the first randomised controlled
trial (RCT)—albeit small and exploratory—to test an inter-
vention specifically for carers in the context of chemotherapy
treatment. It aimed to test proof of concept by studying feasi-
bility, acceptability and potential to effect change in outcomes




The study adopted a two-phased mixed-method research de-
sign—underpinned by the MRC framework for developing
and evaluating complex interventions [29]. It comprised i) a
small exploratory RCT to provide evidence of impact and ii)
embedded focus groups with carers and healthcare profes-
sionals to determine feasibility and acceptability of the inter-
vention process and the instruments used (including timing of
their administration) to measure impact.
‘Take Care’ intervention
The intervention was developed using experience-based co-
design [30, 31]. This is an action research process that takes a
user-centred orientation (by adopting a narrative story-telling
approach) and centres around a participatory, collaborative co-
design process [30]. The intervention—which became known
as ‘Take Care’—was co-designed by HCPs and carers from a
cancer service in a large teaching hospital in England and the
project steering group.
‘Take Care’ aimed to provide information and support to
carers of people about to start a course of chemotherapy. It
comprised a 19-min supportive/educative DVD, an accompa-
nying booklet and 1-h protocol-guided group consultation
conducted by one of two chemotherapy nurses trained in
group facilitation The consultation was provided prior to pa-
tients’ first cycle of treatment to groups of no more than five
carers. During it, they watched the DVD and were provided
opportunity to freely express concerns and ask questions. The
DVD and booklet included information, advice and practical
tips from carers and HCPs on topics including treatment side
effects; impact of being a carer and dealing with emotions; and
importance for carers of taking time out for themselves and
accessing support. The booklet additionally provided hospital-
specific information including maps and contact numbers.
Carers were provided a copy of both the ‘Take Care’ DVD
and booklet and were encouraged to consult both if and when
they needed information and/or support during the patients’
treatment.
Sample and setting
A sample of 40–50 carers was sought as recommended for an
exploratory trial [32, 33]. A consecutive convenience sample
of 47 was recruited. Carers were accessed through patients
being treated with chemotherapy on a day unit in the large
London teaching hospital where the intervention was devel-
oped. Members of the clinical team identified eligible patients.
They were approached by the researcher at the pre-
chemotherapy consultation and provided an information pack
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about the study. Pre-chemotherapy consultation sessions are
information sessions usually delivered by nurses before che-
motherapy treatment begins. Patients providing written con-
sent, confirming their willingness for their carer to participate,
introduced the researcher to their carer. Eligible patients were
over 18 years, chemotherapy naïve, and due to start IV che-
motherapy for breast, lung or colorectal cancer. These patient
groups were recruited as they are amongst the most common
cancers worldwide and are frequently treated with chemother-
apy [34]. Eligible carers were over 18 years and nominated by
patients as providing them with the majority of their support.
Carers were excluded if they or the patients had comprehen-
sion difficulties through cognitive impairment or psychiatric
illness or were unable to speak, read and write in English.
A subsample of carers took part in a focus group at the end
of the study. Eligible carers had received the intervention and
were willing to discuss their experiences of it. They were
sampled purposively to provide variation in terms of carers’
age, gender and relationship to the patient. Six carers were
sought; 21 were approached, six consented and four attended
(two others had been unable to contribute due to patients’
declining health). A further focus group was attended by
HCPs. Six HCPs were sampled purposively to include those
that were either involved in intervention delivery or affected
by its introduction.
Trial procedures
The study commenced after National Research Ethics Service
Committee (ref: 11/LO/0100) and NHS Foundation Trust ap-
provals (ref: RJ1 11/N140) were attained.
Participating carers completed baseline questionnaires
(provided in person to the patient and/or carer when on the
chemotherapy day unit) before they were randomly assigned
between the intervention and control groups by simple
randomisation using a table of randomly generated numbers.
Randomisation and group allocation were undertaken by a
member of the research team not involved in recruitment.
Carers recruited to the intervention attended a Take Care
group consultation within 2 weeks of randomisation. Ques-
tionnaire completion was repeated 4 weeks after baseline
(questionnaires were sent and returned by post).
Instruments
Outcomes selected to measure the impact of the intervention
were the following:
& Knowledge of chemotherapy and its side effects (investi-
gator-developed series of nine 100-mm visual analogue
scales (VASs))
& Unmet needs for information (seven items from the infor-
mation subscale from the Supportive Care Needs Survey
for Partners and Carers [SCNS-P&C44]) [35]
& Experience of care (investigator-designed 11-item Likert-
scale tool)
& Perceived confidence in supporting friend/relative (inves-
tigator-developed six-item numerical rating scale based on
Schwarzer and Fuchs [36])
& Emotional wellbeing (GHQ-12) [37]
Focus groups were facilitated by a member of the research
team (VT) and guided by schedules addressing feasibility,
acceptability and potential utility of the intervention; modifi-
cations required before testing in a larger trial; and the appro-
priateness of the questionnaire including its measures and
timing; HCPs were additionally asked about their experiences
of delivering the intervention and how this might fit with
current practice.
Data analysis
Although the study was an exploratory trial, and inadequately
powered to detect significant differences, scores were exam-
ined on the outcome measures pre- and post-intervention and
between the intervention and control groups to assess trends in
the data and likelihood of the intervention achieving the de-
sired effect.
Analyses of covariance (ANCOVAs) were computed to
determine differences in outcome by study arm. Follow-up
scores of chemotherapy knowledge (individual 100 mm
VAS scores), unmet need for information (sum of number of
unmet needs for information subscale items of SCNS-P&C),
perceived confidence (individual 0–10 NRS scores) and emo-
tional wellbeing (total GHQ12 score: 0–3 scoring) were input
as independent variables; baseline scores as covariates; and
trial arm data as grouping factor.
Multinomial regression was used to analyse individual in-
formation need items scored on the information subscale of
the SCNS-P&C. Logistic regression was used to analyse in-
dividual GHQ12 items and ordinal regression to analyse ex-
perience of, and satisfaction with, care items. Across all re-
gression analyses, follow-up data were specified as the depen-
dent variable and baseline scores and trial arm data as inde-
pendent variables.
The feasibility of the trial design was explored through
analysing recruitment, retention and attrition rates.
Focus groups were recorded digitally, transcribed and
analysed thematically by a member of the research team
(VT). Analysis drew on methods used in framework
analysis [38]. A thematic framework was used to clas-
sify and organise data according to key themes and
categories.
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Results
Sociodemographic characteristics
The estimated recruitment rate of ten carers per month proved
feasible in this particular study setting. Forty-seven carers
were recruited to the study over 16 weeks in 2012
(Fig. 1); 24 were randomly assigned to the intervention
and 23 to the control. Randomisation was acceptable to
carers; none declined on learning that random allocation
was required. Two carers allocated to the intervention
arm did not attend the intervention session and two
(one intervention, one control) were lost to follow-up
(9 % attrition). All four were excluded from analysis.
Participant characteristics were similar across study arms
(Table 1).
Overall response rate to the baseline questionnaire was
59 % (47 out of 80 carers invited to participate took part).
Paents assessed for
inclusion in study (n=269) 
Excluded/ ineligible paents (n= 158)
• Second line tx (n=95) 
• Treatment cancelled (n=3) 
• Oral chemo (n=58) 
• No English (n=2) 
Excluded paents (n=31) 
• No carer (n=31) 
Invited to parcipate
(paents) (n=111) 
Agreed to parcipate and
T1 quesonnaires 
completed (n=47) 
 Allocated to control (n=23) Allocated to intervenon (n=24) 
Reasons for arion
- Did not return 
quesonnaire (n=1) 
Reasons for arion:  
- Did not aend 
consultaon (n=2) 
- Did not return T1 
quesonnaire (n=1) 
Control (n=22)Intervenon (n=21) 
Invited to focus group (n=12) 
Allocaon
Follow-up
Carer refusal (n=33) 
• Full me work (n=17) 
• Inconvenient me (n=2) 
• Own health problems (n=4)  
• Living overseas (n=1) 
• Caring for baby (n=1) 
• Too far to travel (n=2)  
• Feeling overwhelmed (n=2) 
• No reason given (n=4) 
Invited to parcipate
(carers) (n=80) 
Aended focus group (n=4) 
Fig. 1 Flow of participants
through the study
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Table 1 Carers’ characteristics
Intervention (n=21) Control (n=22) Total
Age mean (range) 54.10 (29–70) 51.50 (24–76) 52.77 (24–76)
n (%) n (%) n (%)
Gender
Male 7 (3) 8 (36) 15 (35)
Female 14 (67) 14 (64) 28 (65)
Patient diagnosis
Breast cancer 7 (33) 7 (32) 14 (33)
Lung cancer 9 (43) 9 (41) 18 (42)
Colorectal cancer 5 (24) 6 (27) 11 (26)
Ethnicity
White British 15 (71) 15 (68) 30 (70)
White Irish 1 (5) 0 1 (2)
Other White background 0 0 0
White and Black Caribbean 0 0 3 (7)
White and Black African 0 3 (14) 0
White and Asian 0 0 1 (2)
Other mixed background 1 (5) 1 (5) 2 (5)
Black or Black British: Caribbean 3 (14) 1 (5) 4 (9)
Black or Black British: African 1 (5) 1 (5) 1 (2)
Other Black background 0 0
Asian or Asian British: Indian 0 1 (5) 1 (2)
Asian or Asian British: Pakistani 0 0 0
Chinese 0 0 0
Other Asian background 0 0 0
Other ethnic group 0 0 0
Domestic status
Single 5 (23) 2 (9) 7 (16)
Married 11 (52) 14 (64) 25 (58)
Widowed 1 (5) 0 1 (2)
Living with partner 4 (19) 4 (18) 8 (18)
Divorced/separated 0 2 (9) 2 (5)
Relationship to person with cancer
Spouse/partner 11 (52) 8 (36) 19 (44)
Son or daughter 4 (19) 7 (32) 11 (26)
Parent 0 2 (9) 2 (5)
Friend 0 3 (14) 3 (7)
Other relative 6 (29) 2 (9) 8 (18)
Employment status
Full time employed 5 (25) 7 (32) 12 (28)
Part time employed 4 (20) 5 (23) 9 (21)
Employed but on sick leave 0 0 0
Employed but on unpaid leave 0 0 0
Unemployed 2 (10) 1 (5) 3 (7)
Retired 8 (40) 6 (27) 14 (33)
Full-time or part-time education 0 0 0
Disabled 0 1 (5) 1 (2)
Full-time domestic responsibilities 1 (5) 2 (9) 3 (7)
Missing 1 1 (2)
Education
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Knowledge of chemotherapy side effects
Across all nine knowledge items, there was a consistent, and
statistically significant, improvement in knowledge of chemo-
therapy side effects and their management in the intervention
group when compared to the control (Table 2). Knowledge
improved for all nine items in the intervention group whereas
in the control group knowledge consistently declined.
Unmet need for information
There was a statistically significant increase in the proportion
of people reporting that they did not have any information
needs or that their information needs were being met between
baseline and follow-up when comparing the intervention to
the control. This applied to 8 out of the 12 items (Table 3).
Four items that were not statistically different between groups
related to discussing concerns with doctors; having informa-
tion about the likely outcome of chemotherapy; having infor-
mation about local healthcare services; and having help in
finding out financial support and benefits for you and/or the
person with cancer.
The average number of unmet information needs (SCNS-
P&C Information Needs Scale) fell from 2.81 (SD 2.09) to
1.10 (1.48) for the intervention group and increased from 2.77
(SD 2.20) to 3.23 (SD 2.22) for the control (mean difference
−2.15, 95 % CI −3.22 to −1.07, p<0.001), confirming what
was found for the individual items (Table 3). The response
BYes, I have this need but it is not being met^ was being used
as a response less often in the intervention group compared to
the control.
Experience of care
Experience of care between baseline and control did not differ
significantly between groups except for one of the four items
(See Table 4). The feeling that staff did not spend enough time
with the carer (C4) improved between baseline and follow-up
for the intervention group but worsened for the control group,
and this difference between groups was statistically
significant.
Satisfaction with care
Carers’ satisfaction with care provided improved more for the
intervention group than the control, and this difference was
statistically significant for five of the seven items (Table 5).
Satisfaction improved consistently across all satisfaction items
in the intervention group whilst in the control group satisfac-
tion more often than not declined.
Confidence in coping
Confidence in coping with the current situation tended to im-
prove between baseline and follow-up for the intervention
group and declined for the control group, but these differences
were not sufficient to achieve statistical significance except for
one item: How confident would you feel in supporting them
[friend/relative] if their health gets worse (mean difference
−1.643 [CI −2.96 to −0.32] p=0.016).
Emotional wellbeing
Change from baseline to follow-up did not differ significantly
between the intervention and control groups for any of the 12
GHQ-12 items or the summed GHQ12 score.
Feasibility, acceptability and potential utility
of the intervention
Focus group discussions with carers and HCPs echoed the
statistical findings. Carers and HCPs reported the intervention
Table 1 (continued)
Intervention (n=21) Control (n=22) Total
No formal qualifications 1 (5) 2 (9) 3 (7)
GCSE/O levels or equivalent 10 (48) 7 (32) 17 (40)
A levels or equivalent 1 (5) 2 (9) 3 (7)
Diploma 2 (10) 2 (9) 4 (9)
Degree 2 (10) 6 (27) 8 (18)
A postgraduate qualification 5 (23) 3 (14) 8 (18)
Accommodation
Owner-occupier 14 (67) 16 (73) 30 (70)
Renting from the council/housing association 4 (19) 4 (18) 8 (18)
Renting from a private landlord 3 (14) 2 (9) 5 (12)
Living in temporary accommodation 0 0 0
Other 0 0 0
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was educative; it enhanced knowledge of symptoms and side
effects, prepared, empowered and reassured carers and in-
creased confidence. The intervention appeared a source of
support that helped legitimise and clarify the carer role and
served to lessen anxiety about the chemotherapy process.
Overall, carers most valued receiving information through
the DVD. They believed the visual aspect enabled them to
digest and retain information easily. They spoke about the
positive impact of watching it, particularly hearing other
carers’ experiences of chemotherapy.
Group delivery of intervention
There was variability in the numbers of carers that attended
the group consultation sessions (range 1–5). The impression
created by carers was that group dynamic and processes were
compromised if too small. Groups of up to five carers—as
intended—appeared optimal. Chemotherapy nurses that deliv-
ered the intervention agreed but spoke of challenges with
managing differing personalities during group consultations—
confirming the importance of training in group facilitation for
chemotherapy nurses delivering the intervention.
Although healthcare professionals believed chemotherapy
nurses were best placed to offer the support package, they
highlighted the importance of liaising with clinical nurse spe-
cialists to identify vulnerable carers who would benefit most
from it.
Timing of intervention
Healthcare professionals and the majority of carers thought
the ‘Take Care’ package should be provided prior to chemo-
therapy, preferably on the same occasion that patients have
their treatment explained to them, to enable carers time to
prepare for it.
Representing diversity
The DVD and booklet both included images of patients and
carers from BME communities. However, mention was made
Table 2 Knowledge of chemotherapy
Knowledge of chemotherapy
(0=insufficient, 100=excellent)
Intervention (n=21) Control (n=22) Mean
diff.a
95 % Prob<t

















A1 How adequate was the information
you have received from doctors/
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A3 How adequate was the practical advice
you have received from doctors/nurses
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A8 How adequate is your knowledge






































aMean difference at follow-up adjusting for baseline value
b Levene’s test of group equality of variance, p=0.022
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that materials could have been more inclusive for people from
diverse ethnic backgrounds.
Timing of outcome measures
All carers stated that 1 month was insufficient time to be able
to measure comprehensively changes over time. They ex-
plained that the full effect of chemotherapy was experienced
later in the process, by around the fourth or fifth cycle of
treatment, depending on treatment regime administered.
Discussion
The exploratory study provided evidence of proof of
concept for the ‘Take Care’ supportive intervention for
carers.
Carers’ satisfaction with care provided was significantly
higher in the intervention group than in the control. The larg-
est between-group difference related to the way carers’ friend/
relative’s symptoms were managed. This may result from the
intervention group’s enhanced understanding of symptoms
and side effects, possibly enhancing both their ability to report






















B1 In the last month, did you need information on what the person
with cancer’s physical needs are likely to be?
Baseline 9 (43) 10 (48) 2 (10) 5 (23) 13 (59) 4 (18) 6.990 0.30
Follow-
up
3 (14) 11 (52) 7 (33) 8 (36) 9 (41) 5 (23)
B2 In the last month, did you need information on what the person
with cancer’s emotional needs are likely to be?
Baselineb 10 (48) 9 (43) 2 (10) 10 (45) 9 (41) 2 (9) 9.824 0.007
Follow-
up
3 (14) 14 (67) 4 (19) 12 (55) 7 (32) 3 (14)
B3 In the last month, did you need information on how to deal with
symptoms and consequences of chemotherapy as they occur at
home?
Baseline 7 (33) 13 (62) 1 (5) 10 (46) 9 (41) 3 (14) 15.184 0.001
Follow-
up
2 (10) 16 (76) 3 (14) 14 (64) 5 (23) 3 (14)
B4 In the last month, did you need information about the benefits
and side effects of treatments so you can participate in decision-
making about the person with cancer?
Baseline 9 (43) 10 (48) 2 (10) 11 (50) 8 (36) 3 (14) 11.892 0.003
Follow-
up
2 (10) 15 (71) 4 (19) 12 (55) 8 (36) 2 (9)
B5 In the last month, did you need to discuss your concerns with the
doctors?
Baseline 4 (19) 11 (52) 6 (29) 6 (27) 9 (41) 7 (32) 2.072 0.355
Follow-
up
5 (24) 10 (48) 6 (29) 10 (46) 6 (27) 6 (27)
B6 In the last month, did you need information relevant to your
needs as a carer/partner?
Baseline 11 (52) 8 (38) 2 (10) 8 (36) 7 (32) 7 (32) 7.788 0.020
Follow-
up
3 (14) 14 (67) 4 (19) 11 (50) 6 (27) 5 (23)
B7 In the last month, did you need information about the likely
outcome of chemotherapy?
Baseline 6 (29) 15 (71) 0 (0) 8 (36) 11 (50) 3 (14) 4.483 0.106
Follow-
up
4 (19) 14 (67) 3 (14) 11 (50) 9 (41) 2 (9)
B8 In the last month, did you need information about support
services for carers/partners of people with cancera?
Baseline 10 (48) 10 (48) 1 (5) 9 (41) 6 (27) 7 (32) 7.406 0.006
Follow-
up
4 (19) 14 (67) 3 (14) 13 (59) 4 (18) 5 (23)
B9 In the last month, did you need information about
complementary therapiesa?
Baseline 8 (38) 7 (33) 6 (29) 7 (31) 6 (27) 9 (41) 5.649 0.017
Follow-
upb
2 (10) 15 (71) 4 (19) 8 (36) 5 (23) 8 (36)
B10 In the last month, did you need help caring for the person with
cancer on a practical level such as changing dressings, giving
medications or bathing?
Baselinec 9 (43) 3 (14) 8 (38) 9 (41) 6 (27) 7 (32) 7.904 0.019
Follow-
up
3 (14) 4 (19) 14 (67) 7 (32) 8 (36) 7 (32)
B11 In the last month, did you need information about local
healthcare services?
Baseline 12 (57) 4 (19) 5 (24) 11 (50) 4 (18) 7 (32) 4.813 0.090
Follow-
up
4 (19) 10 (48) 7 (33) 10 (46) 6 (27) 6 (27)
B12 In the last month, did you need help to find out financial
support and benefits for you and/or the person with cancera?
Baselinec 6 (28) 6 (28) 8 (36) 9 (41) 6 (27) 7 (32) 0.823 0.364
Follow-
up
5 (24) 7 (33) 9 (43) 9 (41) 6 (27) 7 (32)
aχ2 with 2° of freedom except B8, B9 and B12 that have 1° of freedom
bOne missing value in the control group
cOne missing value in the intervention group
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symptoms early and boosting their confidence in seeking HCP
support for their amelioration.
In terms of experience of care, changes observed between
baseline and follow-up did not differ significantly between
groups except for one of the four items—the feeling that ‘staff
did not spend enough time with the carer’. Given the nature
and content of the intervention, it is not surprising that the
intervention group reported having more sufficient time with
HCPs. However, it was surprising that they showed little im-
provement across the other three items. Similarly, the level of
emotional wellbeing appeared similar across the study groups.
This was surprising, particularly given the positive find-
ings from the carer focus group at the end of the study
suggesting that carers felt reassured and supported emo-
tionally by the intervention. Carers previously have re-
ported feeling isolated by, and distressed with, their car-
er role and the emotional ‘burden’ it generates [5]. This
outcome may, however, reflect the instrument used to
measure emotional wellbeing. Although well validated,
the GHQ-12 performs less well than other short tools
including the Hospital Anxiety and Depression Scale
[39] and was developed to detect psychiatric disorders
rather than emotional distress.
Both carers and HCPs articulated strong support for the
intervention in the focus groups and believed it increased
carers’ confidence and sense of empowerment. These beliefs
were reflected in the outcome measures; confidence in caring
for patients was higher in the intervention group on complet-
ing the study than in the control, but this failed to reach sig-
nificance. This may have resulted from the exploratory study
being underpowered (as would be expected given its scale and
scope); the scale used to measure confidence in caring being
insufficiently sensitive; or the timing of the follow-up ques-
tionnaires being unsuitable. Arguably, 1monthmay have been
an insufficient time period for carers to have developed con-
fidence in their role. A follow-up questionnaire at 2 months
may have been more suitable.
All participants valued the complementary components of
the ‘Take Care’ package: DVD, booklet and consultation with
the carer support nurse. The group consultation was appreci-
ated by carers as it provided them opportunity to share expe-
riences, exchange information, support others and be support-
ed by HCPs. Further, it legitimised their carer role. Carer sup-
port nurses concurred that the group dynamic was important.
This would suggest that future delivery of the intervention
should incorporate group rather than individual carer
Table 4 Experience of care
Experience of care Time-
point









C1 Experience of care: The staff have listened to
what was worrying me
Intervention Baseline 3 (14) 12 (57) 6 (29) 0 0 0 2.081 0.149
Follow-
up
5 (24) 12 (57) 3 (14) 1 (5) 0 0
Control Baseline 4 (18) 10 (46) 7 (32) 1 (5) 0 0
Follow-
up
4 (18) 9 (41) 5 (23) 4 (18) 0 0
C2 Experience of care: I have felt my own views
of my friend’s/relative’s illness were fully
considered
Intervention Baseline 3 (14) 9 (43) 6 (29) 3 (14) 0 0 3.222 0.073
Follow-
up
1 (5) 16 (76) 2 (10) 2 (10) 0 0
Control Baseline 5 (23) 7 (32) 9 (41) 1 (5) 0 0
Follow-
up
4 (18) 9 (41) 5 (23) 3 (14) 1 (5) 0
C3 Experience of care: I have felt able to express
myself and ask questions
Intervention Baseline 7 (33) 9 (43) 3 (14) 2 (10) 0 0 2.468 0.116
Follow-
up
4 (19) 13 (62) 2 (10) 2 (10) 0 0
Control Baseline 4 (18) 10 (45) 6 (27) 1 (5) 0 1 (5)
Follow-
up
5 (23) 6 (27) 8 (36) 2 (9) 0 1 (5)
C4 Experience of care: I have felt the staff did
not spend enough time with me
Intervention Baseline 1 (5) 2 (10) 5 (24) 10 (48) 3 (14) 0 6.063 0.014
Follow-
up
1 (5) 1 (5) 4 (19) 12 (57) 3 (14) 0
Control Baseline 0 2 (9) 5 (23) 10 (46) 5 (23) 0
Follow-
up
2 (9) 3 (14) 9 (41) 7 (32) 1 (5) 0
aχ2 with 1° of freedom for C1 and C2 and 2° of freedom for C3 and C4
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consultations with a support nurse. Apart from the economic
benefits of group-delivered interventions, they are effective in
reducing psychological and emotional consequences of cancer
and often yield better coping outcomes than those using other
methods of delivery [28].
Results of the exploratory trial indicate the intervention
would be amenable to a large-scale trial. Some revision to
outcome measures is indicated. Whilst trends were detected
in enhanced perceived confidence in caregiving following the
intervention, a scale to measure preparedness for caregiving
such as that developed by Henriksson et al. [40] would appear
more suitable to capture changes generated by the interven-
tion. Future studies should incorporate such a measure.
Future research efforts should be directed at maximising
response rates and minimising attrition by offering the inter-
vention at times to best accommodate carers who work full
time or have other responsibilities. Both carers and HCPs
advocated delivering the intervention as early as possible in
the chemotherapy process. There was consensus the chemo-
therapy consultation may be the most appropriate time to offer
the intervention. HCPs suggested allowing additional time at
the end of the consultation to address carers’ needs. However,
participants stressed that it should also be available at other
times to ensure carers who do not attend the patient’s consul-
tation could still access it.
Strengths and weaknesses of the study
It is important to recognise the limitations of this study in
addition to those already raised. The small sample size may
limit generalisability. The exploratory trial was conducted in
one centre, and there may be aspects of feasibility we have not
Table 5 Satisfaction with care
Satisfaction with care Time-point n (%) χ2b p
Not at all Barely Quite Very Completely Missing
C5 How satisfied were you with the
information given to you about your
relative’s/friend’s chemotherapy by
doctors and nurses?
Intervention Baseline 0 4 (19) 5 (24) 12 (57) 0 0 3.901ª 0.048
Follow-up 0 1 (5) 9 (43) 6 (29) 5 (24) 0
Control Baseline 0 4 (18) 11 (50) 4 (18) 3 (14) 0
Follow-up 2 (9) 7 (32) 7 (32) 3 (14) 3 (14) 0
C6 How satisfied were you with the extent
to which you have been involved in
decisions about care?
Intervention Baseline 1 (5) 4 (19) 10 (48) 6 (29) 0 0 5.366 0.021
Follow-up 0 3 (14) 7 (33) 7 (33) 4 (19) 0
Control Baseline 0 6 (27) 10 (46) 4 (18) 2 (9) 0
Follow-up 2 (9) 6 (27) 9 (41) 4 (18) 1 (5) 0
C7 How satisfied were you with the extent
to which your worries and concerns have
been considered?
Intervention Baseline 2 (10) 3 (14) 7 (33) 9 (43) 0 0 5.808 0.016
Follow-up 0 2 (10) 6 (29) 7 (33) 5 (24) 1 (5)
Control Baseline 1 (5) 4 (18) 11 (50) 3 (14) 2 (9) 1 (5)
Follow-up 4 (18) 5 (23) 7 (32) 5 (23) 1 (5) 0
C8 How satisfied were you with the
nurses’/doctors’ awareness of your
needs?
Intervention Baseline 3 (14) 4 (19) 5 (24) 8 (38) 1 (5) 0 3.383 0.066
Follow-up 0 3 (14) 8 (38) 7 (33) 2 (10) 1 (5)
Control Baseline 0 5 (23) 10 (45) 4 (18) 2 (9) 1 (5)
Follow-up 3 (14) 5 (23) 8 (36) 5 (23) 1 (5) 0
C9 How satisfied were you with the extent to
which your family’s needs have been
considered by doctors and nurses?
Intervention Baseline 3 (14) 5 (24) 7 (33) 6 (29) 0 0 6.655 0.010
Follow-up 1 (5) 2 (10) 9 (43) 5 (24) 4 (19) 0
Control Baseline 1 (5) 7 (32) 9 (41) 4 (18) 0 1 (5)
Follow-up 4 (18) 4 (18) 10 (46) 1 (5) 3 (14) 0
C10 How satisfied were you with the way
in which your friend’s/relative’s symptoms
were managed?
Intervention Baseline 1 (5) 3 (14) 6 (29) 9 (43) 2 (10) 0 9.970 0.002
Follow-up 0 1 (5) 3 (14) 12 (57) 5 (24) 0
Control Baseline 1 (5) 2 (9) 12 (55) 4 (18) 2 (9) 1 (5)
Follow-up 2 (9) 5 (23) 7 (32) 7 (32) 1 (5) 0
C11 How satisfied were you with the
overall care that has been provided?
Intervention Baseline 0 2 (10) 5 (24) 7 (33) 7 (33) 0 1.230 0.267
Follow-up 0 2 (10) 4 (19) 11 (52) 4 (19) 0
Control Baseline 2 (9) 3 (14) 11 (50) 4 (18) 2 (9) 0
Follow-up 1 (5) 5 (23) 7 (32) 8 (36) 1 (5) 0
ªTest of parallel lines significant
bχ2 with 1° of freedom
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tested. For example, it may not be possible to accommodate a
group consultation for carers into clinical pathways in the
same manner at other centres.
The responses of participants to the questionnaires were
based on self-report and possibly subject to recall bias. Also,
only three tumour types were included in the trial sample:
breast, lung and colorectal. This means that findings cannot
be generalised to carers in other tumour groups. Another lim-
itation is that the study recruited primarily Caucasian carers
and only English speakers. Consequently, the views of carers
from Black and minority ethnic groups are underrepresented.
Conclusion
This study tested, through an exploratory trial, an intervention
designed to support carers of people about to receive chemo-
therapy. The intervention proved acceptable to both carers and
HCPs and demonstrated considerable promise and utility in
practice. The findings of this study suggest the intervention
warrants investigation within the context of a fully powered
RCT to determine effectiveness and cost-effectiveness.
Funding This research was funded by Dimbleby Cancer Care.
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